Description
The U.S. Army’s Capability Program Executive for CBRN Defense is establishing a continuous “Participant Basic Agreement” (PBA) ecosystem to recruit pre‑qualified partners for the development, testing, and fielding of next‑generation CBRN medical countermeasures (MCMs) and diagnostics. Companies may submit a concise white paper (≤ 5 pages) describing their capabilities, products, or services and indicating willingness to collaborate. The effort spans host‑targeted therapeutic candidates, threat‑targeted neutralizers, point‑of‑need diagnostic platforms, and supporting services such as CRO/CDMO capabilities, BSL‑3/4 testing, and IP sharing. Successful entrants will be eligible for follow‑on project orders under the PBA, with funding and duration determined on a case‑by‑case basis.
• Targeted collaborators: MCM developers (any TRL), CRO/CDMOs, diagnostic developers (point‑of‑need, host‑response, agent‑specific), and enabling support partners.
• Submission: A ≤ 5‑page white paper to the listed Army email; no explicit due date—treated as open‑ended.
• Requirements: SAM registration mandatory before invoicing; no competition act applicability; awards under 10 U.S.C. §§4021‑4023.
Attached files
Contact
Hunter T Robinson